Synlett 2018; 29(07): 933-937
DOI: 10.1055/s-0036-1591919
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Symmetrical N-Aryl-C-phosphonoacetamidines

Elena B. Erkhitueva
a   Saint Petersburg State University, Universitetskaya nab. 7–9, St. Petersburg 199034, Russian Federation
,
Taras L. Panikorovskii
a   Saint Petersburg State University, Universitetskaya nab. 7–9, St. Petersburg 199034, Russian Federation
,
Nataly I. Svintsitskaya*
b   Saint Petersburg State Institute of Technology (Technical University), Moskovskii pr. 26, St. Petersburg 190013, Russian Federation   Email: nsvincickaya@mail.ru
,
Rostislav Е. Trifonov
a   Saint Petersburg State University, Universitetskaya nab. 7–9, St. Petersburg 199034, Russian Federation
b   Saint Petersburg State Institute of Technology (Technical University), Moskovskii pr. 26, St. Petersburg 190013, Russian Federation   Email: nsvincickaya@mail.ru
,
Аlbina V. Dogadina
b   Saint Petersburg State Institute of Technology (Technical University), Moskovskii pr. 26, St. Petersburg 190013, Russian Federation   Email: nsvincickaya@mail.ru
› Author Affiliations

This work was financially supported by the Russian Foundation for Basic Research (Grant no. 16-03-00474).
Further Information

Publication History

Received: 05 December 2017

Accepted after revision: 04 January 2018

Publication Date:
06 February 2018 (online)

 


Abstract

An efficient synthesis of a series of novel symmetrical N-aryl-C-phosphonoacetamidines through reaction of diisopropyl (chloroethynyl)phosphonate with primary aryl amines was developed. This procedure tolerates a wide range of functional groups and has a good atom economy. The (E)-isomer was the major product that crystallized preferentially over the (Z)-isomer.


#

The amidine motif is present in many naturally occurring compounds and biologically active synthetic compounds.[1] Amidine derivatives have been exploited as useful substrates for the synthesis of valuable organic compounds,[1] [2] ligands,[3] and organic bases.[4] Furthermore, due to their unique structural properties amidines exhibit a ­variety of biological activities that make them potential candidates for drug-discovery programs.[5] The introduction of an aryl or heteroaryl group at a nitrogen atom of an ­amidine attenuates the basic properties of the core, permitting various lipophilic groups to be appended and, in turn, opening the way to the creation of novel compounds with diverse biological activities.[6] Compounds containing the N-arylamidine moiety have shown promise as treatments for inflammation[7] and pain.[8] N-Arylamidines can serve as precursors for the synthesis of biologically important hetero­cycles such as imidazoles,[9] benzimidazoles,[10] quinazolinones,[11] or quinazolines.[12] This clearly identifies N-arylamidines as emerging privileged structures.

Phosphonates and their derivatives are useful in biochemistry,[13] in organic synthesis,[14] and in medicinal[15] and agricultural chemistry.[16] As a result of these diverse applications, the development of efficient approaches to the ­synthesis of new types of organophosphorus compounds has become an promising challenge in organic synthesis. Combinations of phosphonate moieties and nitrogen atoms in multifunctional compounds might result in improved synthetic and biological potentials.[17] Amidines bearing a phosphoryl group have been reported over several decades;[18] [19] however, reports on the synthesis of symmetrical phosphonoamidines are rare.[20–22] Sinitsa and co-workers[20] reported the synthesis of N-alkylated symmetrical amidines by treating a (gem-dichlorovinyl)phosphonate with primary amines. An alternative preparation of symmetrical phosphonoamidines starting from a phosphorylated ketenimine had been reported by Motoyoshiya et al.[22]

Phosphonoketenimines and -ynamines, which are ­highly reactive species and useful synthetic intermediates, are suitable sources for obtaining phosphorylated amidines. Recently, an efficient approach to the synthesis of non­symmetrical C-phosphonoacetamidines through the reaction of ynaminephosphonates[19] or keteniminephosphonates[23] with primary aromatic amines or NH-tetrazoles has been described. Depending on the basicity and nature of the amine, direct amination of (chloroethynyl)phosphonates ­affords amidines or enediamines through formation of an intermediate ynamine.[19]

A possibility of synthesizing symmetrical C-phosphonoamidines through the reaction of a (chloroethynyl)phosphonate with primary aromatic amines such as aniline or p-anisidine has been reported.[24] However, neither the structure of the resulting compounds nor the scope and limitations of the conversion were studied in detail.

Because of the importance of amidines, and in continuation of our studies on the chemistry of functionalized amino­phosphorus compounds,[23] [25] we report a simple synthesis of novel symmetrical N-aryl-C-phosphonоaсetamidines 3ar by treating a (chloroethynyl)phosphonate with primary aryl amines.

In our first attempt, we reacted diisopropyl (chloroethynyl)phosphonate (1) with aniline (2a) in absolute ­diethyl ether without any additive. A two-fold excess of ­aniline was used as the hydrogen chloride acceptor. After stirring the reaction mixture at 0 °C for 16 hours, the ­amidine 3a was isolated in 68% yield (Table [1], entry 1).

Table 1 Optimization the Synthesis of N-Aryl Phosphonoaceta­midinesa

Entry

Amine (equiv)

K2CO3 (equiv)

Solvent

Temp (°C)

Time (h)

Yield (%)b

 1

4

0

Et2O

  0

16

68

 2

2

1

Et2O

 20

10

74

 3

4

0

CH2Cl2

 40

 9

72

 4

2

1

CH2Cl2

 40

 7

75

 5

4

0

CCl4

 80

 6

75

 6

2

1

CCl4

80

4

89

 7

4

0

MeCN

 82

 6

73

8

2

1

MeCN

82

5

87

 9

4

0

toluene

110

 5

75

10

2

1

toluene

110

 3.5

85

a Reaction conditions: 1a (1 mmol), PhNH2 (2a; 2–4 equiv), K2CO3 (0–1 equiv), solvent (10 mL).

b Yield of isolated pure compound after crystallization from hexane.

It is known that amines of moderate or low basicity are incapable of rapidly trapping the evolved hydrogen chloride, whereupon hydrochlorination of the intermediate ynamine across the triple bond can occur, decreasing the reaction rate.[19] For this reason, we examined the use of ­potassium carbonate as the HCl acceptor. In the presence of one equivalent of K2CO3, the reaction proceeded at room temperature within ten hours to give the desired amidine 3a in 74% yield (Table [1], entry 2). The use of one equivalent of K2CO3 in refluxing anhydrous carbon tetrachloride required a shorter reaction time of four hours to convert phosphonate 1a completely into amidine 3a in 89% yield (Table [1], entry 6). Changing the solvent to higher-boiling toluene or polar acetonitrile did not have a marked effect on the outcome of the reaction (Table [1], entries 8 and 10). However, because of the toxicity of carbon tetrachloride, the use of acetonitrile as the solvent is far preferable in our opinion.

A series of symmetrical N-aryl amidines 3ar was prepared from various primary aryl amines 2ar and diiso­propyl (chloroethynyl)phosphonate (1) under the optimized reaction conditions (Table [2]).[26] The scope of the primary aryl amine was tested. Anilines substituted by an electron-donating group such as 4-methoxy (Table [2], entry 3) or 4-methyl (Table [2], entry 2) showed an increased reactivity. Note that 4-aminophenol (2d) (Table [2], entry 4) led to the formation ofgave only a trace of the target product as a result of the involvement of the hydroxy group in the reaction (Table [2], entry 4). With halo-substituted substrates, the highest yield (82%) was obtained from 4-chloroaniline 2f (Table [2], entry 6). The trend in the reactivity of 4-halo­anilines was F > Cl > Br > I. Substrates with an electron-withdrawing nitro, trifluoromethyl, or acetyl group were tolerated under the reaction conditions, giving moderate yields of the corresponding symmetrical arylamidines (­Table [2], entries 9–11). In the case of 1-(4-amino­phenyl)ethanone (2k), toluene was used as the solvent (Table [2], entry 11).

Table 2 Synthesis of Symmetrical Phosphonoacetamidines 3a–r

Entry

Adduct

R1

R2

Time (h)

Yield (%)a

 1

3a

H

H

 5

87

 2

3b

4-Me

H

 6.5

88

 3

3c

4-OMe

H

 5

93

 4

3d

4-OH

H

20

trace

 5

3e

4-F

H

 5

81

 6

3f

4-Cl

H

 6

82

 7

3g

4-Br

H

 6.5

78

 8

3h

4-I

H

21

72

 9

3i

4-CF3

H

 8

81

10

3j

4-NO2

H

21

43

11b

3k

4-Ac

H

15

65

12

3l

2-OMe

5-Me

14

88

13

3m

2-Me

4-Me

16

81

14

3n

2-OMe

4-NO2

25

45

15

3o

2-Cl

4-Cl

18

85

16

3p

2-F

4-Br

20

72

17

3q

3-F

4-F

 8.5

93

18

3r

3-CF3

5-CF3

17

69

a Yields of isolated pure compounds after crystallization from hexane.

b Toluene was used as the solvent.

A marked decrease in reactivity (43% yield) was observed when 4-nitroaniline (2j) was used as the reactant (Table [2], entry 10). Disubstituted anilines 2lr provided moderate to high yields of the target products. 2,4-Dichloro­aniline (2o) and 3,4-difluoroaniline (2q) gave the highest yields of the corresponding symmetrical amidines (85 and 93%, respectively).

The structures of amidines 3ar were confirmed by IR and 1Н, 13C, 19F and 31P NMR spectroscopy. The 1Н NMR spectra of the symmetrical phosphonoacetamidines 3ar contained a characteristic doublet signal for the methylene PCН2 protons in the range δ = 2.82–3.08 with a spin–spin coupling constant (2 J HP) of 19.3–24.1 Hz. The signal for the NH proton was observed at δ = 7.74–9.76 ppm. In the 13C NMR spectra, the signal for the carbon atom adjacent to the phosphorus atom appeared as a doublet at δC = 29.13–30.95, with coupling constants of 1 J CP = 129.1–136.2 Hz, typical of phosphonates with an sp3-hybridized carbon ­atom. The azomethyne carbon resonated at a lower field at δC = 146.47–150.23 with a spin–spin coupling constant of 2 J CP = 5.1–7.3 Hz. The chemical shifts of the phosphorus ­nuclei in adducts 3ar appeared in the range δP = 19–23 ppm. The IR spectra of compounds 3ar contained strong absorption bands at 1500–1657 cm–1, assigned to the C=N bond stretching.

The structures of compounds 3b, 3k, and 3l [27] were confirmed by X-ray single-crystal studies (Figures [1] and 2, and Supplementary Information Figure S1). These compounds crystallized in a monoclinic space group (P21/c or P21/n) with one molecule in the asymmetric unit cell. The bond lengths and angles coincided with those typically found in similar compounds, and the molecules were not sterically strained. It is likely that only the (E)-isomer crystallized, due to the steric hindrance imparted by the diisopropylphosphoryl fragment. In the crystal, the (E)-configuration of the amidine fragment is stabilized by intramolecular hydrogen bonding between the phosphoryl oxygen, imine, and aryl ortho-CH moieties. For ­example, in the crystal of 3l, the following intramolecular interactions were observed: N2–H···O1–P1 2.480 Å, C1=N1···H–C12, C6–H···O3=P1 2.478 Å, C1=N1···H–C12 2.326 Å (Figure [2]).

Zoom Image
Figure 1 Single-crystal structure of compound 3k (CCDC 1505945).
Zoom Image
Figure 2 Single-crystal structure of compound 3l (CCDC 1518068).

To evaluate the configuration of the symmetrical N-aryl-C-phosphonoacetamidines 3ar in solution, we performed 2D NOESY experiments for all the compounds obtained, with CDCl3 and DMSO-d 6 as solvents. In the spectra of the 4-methoxyarylamidine 3c and 4-haloarylamidines 3eg in CDCl3, cross-peaks between the diisopropylphosphoryl moiety and the protons of the imino­aryl ring were observed, indicating an (E)-configuration of the C=N double bond. These interactions were not observed when polar DMSO-d 6 was used as a solvent. Another trend was observed in the case of the 4-iodoaryl derivative 3h, where cross-peaks between the methyl protons of the isopropyl group (δ = 1.21 ppm) and the ortho-protons of the imino­aryl ring (δ = 7.72 ppm) were observed in DMSO-d 6 solution, but no cross-peaks were observed in CDCl3 solution. The NOESY results therefore showed that for N-arylamidines 3il and 3n, the (E)-isomer is predominant in both CDCl3 and DMSO-d 6 solutions. In contrast, for the phenyl derivative 3a and the 4-tolyl derivative 3b, no correlation between the signals of the diisopropylphosphoryl and imino­aryl moieties was found in either CDCl3 or DMSO-d 6. Identical results were obtained in the case of disubstituted N-aryl amidine 3r. For compounds 3m, 3o, and 3p, NOESY experiments showed a correlation between the signals of the methyl protons of the isopropyl group and the ortho-­protons of the iminoaryl ring only when nonpolar CDCl3 was used as the solvent, indicating the presence of the (E)-isomer.

In conclusion, we have developed an efficient approach for the synthesis of novel symmetrical N-aryl-C-phosphonoacetamidines. This strategy tolerates a variety of aryl amines to furnish N-aryl-C-phosphonoacetamidines that might serve as key intermediates in syntheses of various heterocyclic compounds of interest in medicinal chemistry.


#

Acknowledgment

This research made use of resources of the Centre for Magnetic Resonance, the Centre for Chemical Analysis and Materials, and the Center for X-ray Diffraction Methods of Saint Petersburg State University.

Supporting Information

  • References and Notes

    • 1a Gautier J.-A. Miocque M. Combet Farnoux C. In The Chemistry of Amidines and Imidates . Patai S. Wiley; London: 1975
    • 1b Boyd GV. In The Chemistry of Amidines and Imidates . Vol. 2. Patai S. Rappoport Z. Wiley; London: 1991: 367
    • 2a Dunn PJ. In Comprehensive Organic Functional Group Transformations . Vol. 5. Katritzky AR. Meth-Cohn O. Rees CW. Pergamon; Amsterdam: 1995: 741
    • 2b Ishikawa T. Kumamoto T. In Superbases for Organic Synthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysts. Ishikawa T. Wiley; Chichester: 2009: 49
    • 2c Aly AA. Nour El-Din AM. ARKIVOC 2008; (i): 153
  • 7 Kort ME. Drizin I. Gregg RJ. Scanio MJ. C. Shi L. Gross MF. Atkinson RN. Johnson MS. Pacofsky GJ. Thomas JB. Carroll WA. Krambis MJ. Liu D. Shieh C.-C. Zhang X. Hernandez G. Mikusa JP. Zhong C. Joshi S. Honore P. Roeloffs R. Marsh KC. Murray BP. Liu J. Werness S. Faltynek CR. Krafte DS. Jarvis MF. Chapman ML. Marron BE. J. Med. Chem. 2008; 51: 407
  • 10 Brasche G. Buchwald SL. Angew. Chem. Int. Ed. 2008; 47: 1932
  • 11 Ma B. Wang Y. Peng J. Zhu Q. J. Org. Chem. 2011; 76: 6362
    • 15a Chen X. Kopecky DJ. Mihalic J. Jeffries S. Min X. Heath J. Deignan J. Lai S. Fu Z. Guimaraes C. Shen S. Li S. Johnstone S. Thibault S. Xu H. Cardozo M. Shen W. Walker N. Kayser F. Wang Z. J. Med. Chem. 2012; 55: 3837
    • 15b Cheng T.-RR. Weinheimer S. Tarbet EB. Jan J.-T. Cheng Y.-SE. Shie J.-J. Chen C.-C. Chen C.-A. Hsieh W.-C. Huang P.-W. Lin W.-H. Wang S.-Y. Fang J.-M. Hu OY.-P. Wong C.-H. J. Med. Chem. 2012; 55: 8657
    • 15c Dang Q. Liu Y. Cashion DK. Kasibhatla SR. Jiang T. Taplin F. Jacintho JD. Li H. Sun Z. Fan Y. DaRe J. Tian F. Li W. Gibson T. Lemus R. van Poelje PD. Potter SC. Erion MD. J. Med. Chem. 2011; 54: 153
    • 15d Alexandre F. Amador A. Bot S. Caillet C. Convard T. Jakubik J. Musiu C. Poddesu B. Vargiu L. Liuzzi M. Roland A. Seifer M. Standring D. Storer R. Dousson CB. J. Med. Chem. 2011; 54: 392
  • 20 Sinitsa AD. Krishtal VS. Kal’chenko VI. Zh. Obshch. Khim. 1980; 50: 1288
  • 21 Köckritz A. Schnell M. Phosphorus, Sulfur Silicon, Relat. Elem. 1992; 73: 185
  • 22 Motoyoshiya J. Teranishi A. Mikoshiba R. Yamamoto I. Gotho H. Enda J. Ohshiro Y. Agawa T. J. Org. Chem. 1980; 45: 5385
  • 23 Svintsitskaya NI. Dogadina AV. Trifonov RE. Synlett 2016; 27: 241
  • 24 Leonov AA. Ph.D. Dissertation . Leningrad State Institute of Technology; USSR: 1984
  • 26 N-Aryl-C-phosphonoacetamidines 3a–s; General Procedure The appropriate aniline 2as (2 mmol) was added to a mixture of diisopropyl (chloroethynyl)phosphonate (1; 1 mmol) and K2CO3 (1 mmol) in anhyd acetonitrile (10 mL) at r.t., and the mixture was stirred vigorously under reflux for 5–25 h. When the reaction was complete, the mixture was filtered and concentrated, and the residue was crystallized from hexane. Diisopropyl {(2E)-2-[(4-Fluorophenyl)amino]-2-[(4-fluorophenyl)imino]ethyl}phosphonate (3e) White needle crystals; yield: 332 mg (81%); mp 104–106 °C. IR (KBr): 995.27 (P–O–C), 1226.73 (P=O), 1500.62 (C=N) cm–1. 1H NMR (400.13 MHz, DMSO-d 6): δ = 1.16 (d, 3 J HH = 6.1 Hz, 6 H, CH3), 1.21 (d, 3 J HH = 6.2 Hz, 6 H, CH3), 2.92 (d, 2 J HP = 21.8 Hz, 2 H, CH2P), 4.53 (m, 3 J HH = 6.1 Hz, 3 J HP = 12.4 Hz, 1 H, CHOP), 4.54 (m, 3 J HH = 6.1 Hz, 3 J HP = 14.0 Hz, 1 H, CHOP), 6.82 [m, 3 J HH = 8.8 Hz, 1 H, o-CH, Ar(NH)], 6.83 [m, 3 J HH = 8.8 Hz, 1 H, o-CH, Ar(NH)], 7.09 (m, 3 J HH = 9.1 Hz, 4 H, m-CH, Ar), 7.73 [m, 3 J HH = 9.2 Hz, 1 H, o-CH, Ar(N=)], 7.75 [m, 3 J HH = 9.2 Hz, 1 H, o-CH, Ar(N=)], 8.66 (s, 1 H, NH). 13C NMR (100.61 MHz, DMSO-d 6): δ = 23.97 (d, 3 J CP = 4.4 Hz, CH3), 24.11 (d, 3 J CP = 4.4 Hz, CH3), 30.25 (d, 1 J CP = 133.5 Hz, CH2P), 70.98 [d, 2 J CP = 6.6 Hz, (OCH)2P], 115.38 [d, 2 J CF = 21.3 Hz, m-CH, Ar(NH)], 115.59 [d, 2 J CF = 22.0 Hz, m-CH, Ar(N=)], 121.02 [d, 3 J CF = 7.3 Hz, o-CH, Ar(NH)], 123.50 [d, 3 J CF = 8.0 Hz, o-CH, Ar(N=)], 137.57 (d, 4 J CF = 1.5 Hz, C-ipso-N=), 146.67 (d, 4 J CF = 1.5 Hz, C-ipso-NH), 148.09 (d, CH2 C, 2 J CP = 7.3 Hz), 157.62 [d, 1 J CF = 239.1 Hz, CF, Ar(NH)], 158.40 [d, 1 J CF = 237.6 Hz, CF, Ar(N=)]. 31P NMR (161.98 MHz, DMSO-d 6): δ = 20.63. 19F NMR (376.50 MHz, DMSO-d 6): δ = –122.72 [F, Ar(NH)], –121.19 [F, Ar(N=)]. ESI-HRMS: m/z [M + H]+ calcd for C20H26F2N2O3P: 411.1660; found: 411.1644.
  • 27 CCDC 1505945 and CCDC 1518068 contain the supplementary crystallographic data for compounds 3k and 3l, respectively. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.

  • References and Notes

    • 1a Gautier J.-A. Miocque M. Combet Farnoux C. In The Chemistry of Amidines and Imidates . Patai S. Wiley; London: 1975
    • 1b Boyd GV. In The Chemistry of Amidines and Imidates . Vol. 2. Patai S. Rappoport Z. Wiley; London: 1991: 367
    • 2a Dunn PJ. In Comprehensive Organic Functional Group Transformations . Vol. 5. Katritzky AR. Meth-Cohn O. Rees CW. Pergamon; Amsterdam: 1995: 741
    • 2b Ishikawa T. Kumamoto T. In Superbases for Organic Synthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysts. Ishikawa T. Wiley; Chichester: 2009: 49
    • 2c Aly AA. Nour El-Din AM. ARKIVOC 2008; (i): 153
  • 7 Kort ME. Drizin I. Gregg RJ. Scanio MJ. C. Shi L. Gross MF. Atkinson RN. Johnson MS. Pacofsky GJ. Thomas JB. Carroll WA. Krambis MJ. Liu D. Shieh C.-C. Zhang X. Hernandez G. Mikusa JP. Zhong C. Joshi S. Honore P. Roeloffs R. Marsh KC. Murray BP. Liu J. Werness S. Faltynek CR. Krafte DS. Jarvis MF. Chapman ML. Marron BE. J. Med. Chem. 2008; 51: 407
  • 10 Brasche G. Buchwald SL. Angew. Chem. Int. Ed. 2008; 47: 1932
  • 11 Ma B. Wang Y. Peng J. Zhu Q. J. Org. Chem. 2011; 76: 6362
    • 15a Chen X. Kopecky DJ. Mihalic J. Jeffries S. Min X. Heath J. Deignan J. Lai S. Fu Z. Guimaraes C. Shen S. Li S. Johnstone S. Thibault S. Xu H. Cardozo M. Shen W. Walker N. Kayser F. Wang Z. J. Med. Chem. 2012; 55: 3837
    • 15b Cheng T.-RR. Weinheimer S. Tarbet EB. Jan J.-T. Cheng Y.-SE. Shie J.-J. Chen C.-C. Chen C.-A. Hsieh W.-C. Huang P.-W. Lin W.-H. Wang S.-Y. Fang J.-M. Hu OY.-P. Wong C.-H. J. Med. Chem. 2012; 55: 8657
    • 15c Dang Q. Liu Y. Cashion DK. Kasibhatla SR. Jiang T. Taplin F. Jacintho JD. Li H. Sun Z. Fan Y. DaRe J. Tian F. Li W. Gibson T. Lemus R. van Poelje PD. Potter SC. Erion MD. J. Med. Chem. 2011; 54: 153
    • 15d Alexandre F. Amador A. Bot S. Caillet C. Convard T. Jakubik J. Musiu C. Poddesu B. Vargiu L. Liuzzi M. Roland A. Seifer M. Standring D. Storer R. Dousson CB. J. Med. Chem. 2011; 54: 392
  • 20 Sinitsa AD. Krishtal VS. Kal’chenko VI. Zh. Obshch. Khim. 1980; 50: 1288
  • 21 Köckritz A. Schnell M. Phosphorus, Sulfur Silicon, Relat. Elem. 1992; 73: 185
  • 22 Motoyoshiya J. Teranishi A. Mikoshiba R. Yamamoto I. Gotho H. Enda J. Ohshiro Y. Agawa T. J. Org. Chem. 1980; 45: 5385
  • 23 Svintsitskaya NI. Dogadina AV. Trifonov RE. Synlett 2016; 27: 241
  • 24 Leonov AA. Ph.D. Dissertation . Leningrad State Institute of Technology; USSR: 1984
  • 26 N-Aryl-C-phosphonoacetamidines 3a–s; General Procedure The appropriate aniline 2as (2 mmol) was added to a mixture of diisopropyl (chloroethynyl)phosphonate (1; 1 mmol) and K2CO3 (1 mmol) in anhyd acetonitrile (10 mL) at r.t., and the mixture was stirred vigorously under reflux for 5–25 h. When the reaction was complete, the mixture was filtered and concentrated, and the residue was crystallized from hexane. Diisopropyl {(2E)-2-[(4-Fluorophenyl)amino]-2-[(4-fluorophenyl)imino]ethyl}phosphonate (3e) White needle crystals; yield: 332 mg (81%); mp 104–106 °C. IR (KBr): 995.27 (P–O–C), 1226.73 (P=O), 1500.62 (C=N) cm–1. 1H NMR (400.13 MHz, DMSO-d 6): δ = 1.16 (d, 3 J HH = 6.1 Hz, 6 H, CH3), 1.21 (d, 3 J HH = 6.2 Hz, 6 H, CH3), 2.92 (d, 2 J HP = 21.8 Hz, 2 H, CH2P), 4.53 (m, 3 J HH = 6.1 Hz, 3 J HP = 12.4 Hz, 1 H, CHOP), 4.54 (m, 3 J HH = 6.1 Hz, 3 J HP = 14.0 Hz, 1 H, CHOP), 6.82 [m, 3 J HH = 8.8 Hz, 1 H, o-CH, Ar(NH)], 6.83 [m, 3 J HH = 8.8 Hz, 1 H, o-CH, Ar(NH)], 7.09 (m, 3 J HH = 9.1 Hz, 4 H, m-CH, Ar), 7.73 [m, 3 J HH = 9.2 Hz, 1 H, o-CH, Ar(N=)], 7.75 [m, 3 J HH = 9.2 Hz, 1 H, o-CH, Ar(N=)], 8.66 (s, 1 H, NH). 13C NMR (100.61 MHz, DMSO-d 6): δ = 23.97 (d, 3 J CP = 4.4 Hz, CH3), 24.11 (d, 3 J CP = 4.4 Hz, CH3), 30.25 (d, 1 J CP = 133.5 Hz, CH2P), 70.98 [d, 2 J CP = 6.6 Hz, (OCH)2P], 115.38 [d, 2 J CF = 21.3 Hz, m-CH, Ar(NH)], 115.59 [d, 2 J CF = 22.0 Hz, m-CH, Ar(N=)], 121.02 [d, 3 J CF = 7.3 Hz, o-CH, Ar(NH)], 123.50 [d, 3 J CF = 8.0 Hz, o-CH, Ar(N=)], 137.57 (d, 4 J CF = 1.5 Hz, C-ipso-N=), 146.67 (d, 4 J CF = 1.5 Hz, C-ipso-NH), 148.09 (d, CH2 C, 2 J CP = 7.3 Hz), 157.62 [d, 1 J CF = 239.1 Hz, CF, Ar(NH)], 158.40 [d, 1 J CF = 237.6 Hz, CF, Ar(N=)]. 31P NMR (161.98 MHz, DMSO-d 6): δ = 20.63. 19F NMR (376.50 MHz, DMSO-d 6): δ = –122.72 [F, Ar(NH)], –121.19 [F, Ar(N=)]. ESI-HRMS: m/z [M + H]+ calcd for C20H26F2N2O3P: 411.1660; found: 411.1644.
  • 27 CCDC 1505945 and CCDC 1518068 contain the supplementary crystallographic data for compounds 3k and 3l, respectively. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.

Zoom Image
Figure 1 Single-crystal structure of compound 3k (CCDC 1505945).
Zoom Image
Figure 2 Single-crystal structure of compound 3l (CCDC 1518068).